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Background: In populations with high levels of immuniza-
tion against measles (MV) and rubella virus (RV), other causes of
rash-fever illness predominate. Enterovirus (EV) can cause a wide
variety of clinical illness, including undifferentiated rash. Therefore
virus surveillanceandgenetic characterizationof circulating strains
causing exhanthematic illness are important tools for regional and
global control efforts. The aims of the present study were: (i)
identify theRVandEVgenotypes isolated in clinical specimensdur-
ing Epidemiological Surveillance on Exanthematic Febrile Diseases
study (VIGIFEX) 2003-2004; and (ii) performphylogenetic analyses
of RV (E1 gene) and EV (VP1 gene).
Methods & Materials: During VIGIFEX surveillance, 30 patients
with RV and 9 patients with EV were identiﬁed. RV were detected
using a commercial EIA for IgM, and EV were identiﬁed by
cytophatic effect in RD and MRC-5 cells and IFA. Ten RV and four
EV positive oropharyngeal samples isolated from SIRC and RD cell
lines, respectively, were subjected to PCR and sequencing for geno-
typing.
Results: Genotype 1G were identiﬁed in all samples involved
in RV infection and showed similarity to sequences from England,
Canada and Brazil (within-group distance, 0.9%). Echovirus 9 (E9)
was isolated from the 4 EV positive samples and the VP1 sequences
displayed the highest nucleotide identity to the strain 99.352.1072
(86.3-87.4% nt; 95.7% aa) detected in Australia in 1999. In addition,
the E-9 isolates in the current study did not fall into any previously
described genogroups A to H and J, and assembled into a sepa-
rated genogroup (designated ), as supported by bootstrap value
of 100%.
Conclusion: RV genotype 1G was ﬁrst isolated during the
2000-2001 outbreaks and has persisted in Brazil ever since. E9 is
frequently associatedwith a rubelliform exanthema; however, this
is the ﬁrst report of E9 involved in exanthematic illness in Brazil.
The E9 VP1 analysis suggested the existence of a new genogroup
with limited circulation, apparently conﬁned to Brazil. This report
broadens the known spectrum of viruses’ involvement in rash and
fever illness, and emphasizes the need for to consider both RV and
EV in the differential diagnosis of exanthematous diseases afterMV
eradication in Brazil.
http://dx.doi.org/10.1016/j.ijid.2014.03.1359
Type: Poster Presentation
Final Abstract Number: 64.030
Session: Virology and Viral Infections (Non-HIV) II
Date: Saturday, April 5, 2014
Time: 12:45-14:15
Room: Ballroom
Occult hepatitis B virus infection in fully
screened blood units in Nigeria
O.O. Opaleye1, A.H. Fagbami1, O.S. Bolaji 2,∗
1 Ladoke Akintola University of Technology, Osogbo,
Nigeria
2 Ladoke Akintola University Of Technology, Osogbo,
Nigeria
Background: Occult hepatitis B virus (HBV) infection (OBI) is
characterized by the presence of HBV DNA without detectable HBV
surface antigen (HBsAg). Nucleic acid testing (NAT) is however
not currently a prerequisite in blood banks of many developing
countries. In this study we investigated the prevalence of OBI in
Nigerian blood donors and the virological factors involved
Methods & Materials: Four hundred and twenty-nine sera col-
lected from fully-screened donors from 2 blood banks in Nigeria
were reafﬁrmed for their HBsAg seronegative status by enzyme
linked immunosorbent assay (ELISA), additionally 40knownHBsAg
positives samples where use as controls. A polymerase chain reac-
tion was used to amplify HBV DNA from these donors. Viral load
was measured using real time quantitative PCR in the OBI samples
and antibodies to the core and surface antigen (anti-HBc, anti-HBs)
as well as the envelope antigen (HBeAg) were assayed. Partial S
region of the HBV genome was sequenced.
Results: All the 429 donor samples tested, were conﬁrmed
HBsAg negative. Of these, 154 (36%) were positive for HBV DNA
after nested PCR. Of the 154, 105 (68%) were positive for anti-HBc,
55 (36%) were anti-HBs positive, and only 3 (2%) were positive
for HBeAg. Averagely the viral load was <50copies/ml in the OBI
samples examined by quantitative PCR and genotype E was the
predominant HBV genotype found. G779 nucleotide substitution
which translated to R217 amino acid mutation at the RT (reverse
transcriptase) domain of the polymerase gene was signiﬁcantly
higher OBI compared with HBsAg positives patients (p <0.0001).
Conclusion: OBI is frequent among blood donors in Nigeria and
could be classiﬁed into 3 groups; those positive for anti-HBc, anti-
HBs andHBVDNA; those positive for anti-HBc andHBVDNAaswell
as those positive for HBV DNA alone. R217 amino acid mutation at
the RT domain of the polymerase gene might be associated to the
occultnatureof theHBV infection in theOBIpatients. Theseﬁndings
underscore the need for NAT in blood donor screening in Nigeria.
http://dx.doi.org/10.1016/j.ijid.2014.03.1360
